1. Home
  2. CMRE vs MPLT Comparison

CMRE vs MPLT Comparison

Compare CMRE & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$14.05

Market Cap

1.9B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$8.02

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
MPLT
Founded
1974
2018
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
CMRE
MPLT
Price
$14.05
$8.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
$20.00
★ $26.54
AVG Volume (30 Days)
★ 347.2K
343.7K
Earning Date
11-03-2026
12-03-2026
Dividend Yield
★ 3.53%
N/A
EPS Growth
N/A
★ 82.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.55
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.45
$7.46
52 Week High
$18.06
$40.43

Technical Indicators

Market Signals
Indicator
CMRE
MPLT
Relative Strength Index (RSI) 38.82 30.63
Support Level $13.86 $7.46
Resistance Level $15.76 $14.22
Average True Range (ATR) 0.45 0.58
MACD -0.10 0.12
Stochastic Oscillator 25.12 23.71

Price Performance

Historical Comparison
CMRE
MPLT

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: